The AIMBE Scholars Program enables distinguished postdoctorates in the medical and biomedical engineering fields to serve as expert advisors to policy makers at the FDA. Scholars learn how to apply their experiences from the lab bench to inform regulatory policy decisions. AIMBE Scholars work side-by-side with the most influential decision makers at the agency–from reviewers to FDA scientists to Center directors. They inform public policy through their knowledge of the latest cutting-edge research and technological innovations. Scholars receive training about regulatory science and policy and build relationships with key government stakeholders. Scholars extend the capacity of the FDA and work toward streamlining regulatory processes at the agency through a variety of projects. They may be involved in standards development and the development of metrics to evaluate and inform agency programs and decision-making.
Some biomedical engineers participating in the AIMBE Scholars Program return to their academic, government, or industry careers–with greater understanding of the connections between public policy and translational science–while others go on to build new careers in regulatory policy.
The goals of the AIMBE Scholars Program are twofold:
(1) To advance regulatory science at the FDA and strengthen the connections between bioengineering and the scientific enterprise, industry, and the regulatory processes that governs the medical device sector; and
(2) As a training program for rising leaders in the field to learn first-hand about the regulatory processes that encompass the medical device total product life cycle.
September 16, 2015: AIMBE Announces 2015-2016 Scholars at FDA
September 16, 2015: AIMBE Announces Renewed Partnership with FDA
September 15, 2014: AIMBE Announces 2014-2015 Scholars at FDA
September 1, 2014: AIMBE Launches Scholars Program
AIMBE Scholars Program
Spotlight on AIMBE FDA Scholars
The AIMBE Scholars Program is a highly competitive program, consisting of one-year immersion experiences from October 1 to September 31 in the Center for Devices and Radiological Health (CDRH) within the U.S. Food and Drug Administration (FDA) on the White Oak Campus in Silver Spring, MD. AIMBE facilitates the Scholars experience throughout the program year. The program includes an orientation to public policy, as well as opportunities to network with regulatory and R&D leaders in both industry and government. Scholars are provided with a yearly stipend of $70,000, plus allowances for moving expenses to Washington and attendance at scientific conferences throughout the program-year.
The application period for the 2016-2017 cycle is now closed.
Questions? Contact Sarah Mandell
Director of Research and Programming at AIMBE